CCN3/NOV gene expression in human prostate cancer is directly suppressed by the androgen receptor
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
CCN3/NOV gene expression in human prostate cancer is directly suppressed by the androgen receptor
Authors
Keywords
-
Journal
ONCOGENE
Volume 33, Issue 4, Pages 504-513
Publisher
Springer Nature
Online
2013-01-14
DOI
10.1038/onc.2012.602
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The mutational landscape of lethal castration-resistant prostate cancer
- (2012) Catherine S. Grasso et al. NATURE
- CCN3 Impairs Osteoblast and Stimulates Osteoclast Differentiation to Favor Breast Cancer Metastasis to Bone
- (2011) Véronique Ouellet et al. AMERICAN JOURNAL OF PATHOLOGY
- Androgen Receptor Gene Expression in Prostate Cancer Is Directly Suppressed by the Androgen Receptor Through Recruitment of Lysine-Specific Demethylase 1
- (2011) Changmeng Cai et al. CANCER CELL
- The CCN3 gene coding for an extracellular adhesion-related protein is transcriptionally activated by the p53 tumor suppressor
- (2011) Levin Böhlig et al. CELL CYCLE
- The androgen receptor fuels prostate cancer by regulating central metabolism and biosynthesis
- (2011) Charles E Massie et al. EMBO JOURNAL
- Cooperation between Polycomb and androgen receptor during oncogenic transformation
- (2011) J. C. Zhao et al. GENOME RESEARCH
- Minireview: Alternative Activation Pathways for the Androgen Receptor in Prostate Cancer
- (2011) Kristin R. Lamont et al. MOLECULAR ENDOCRINOLOGY
- Reprogramming transcription by distinct classes of enhancers functionally defined by eRNA
- (2011) Dong Wang et al. NATURE
- Taking aim at the extracellular matrix: CCN proteins as emerging therapeutic targets
- (2011) Joon-Il Jun et al. NATURE REVIEWS DRUG DISCOVERY
- Association of the metastatic phenotype with CCN family members among breast and oral cancer cells
- (2011) Toshihiro Ohgawara et al. Journal of Cell Communication and Signaling
- An Integrated Network of Androgen Receptor, Polycomb, and TMPRSS2-ERG Gene Fusions in Prostate Cancer Progression
- (2010) Jindan Yu et al. CANCER CELL
- The Gene Encoding the Hematopoietic Stem Cell Regulator CCN3/NOV Is under Direct Cytokine Control through the Transcription Factors STAT5A/B
- (2010) Akiko Kimura et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Inhibition of cyclin D1 expression by androgen receptor in breast cancer cells--identification of a novel androgen response element
- (2010) M. Lanzino et al. NUCLEIC ACIDS RESEARCH
- The neuronal repellent SLIT2 is a target for repression by EZH2 in prostate cancer
- (2010) J Yu et al. ONCOGENE
- Histone Deacetylases Are Required for Androgen Receptor Function in Hormone-Sensitive and Castrate-Resistant Prostate Cancer
- (2009) D. S. Welsbie et al. CANCER RESEARCH
- Androgen Receptor Regulates a Distinct Transcription Program in Androgen-Independent Prostate Cancer
- (2009) Qianben Wang et al. CELL
- Matricellular Protein CCN3 (NOV) Regulates Actin Cytoskeleton Reorganization
- (2009) Wun-Chey Sin et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Integrated Expression Profiling and ChIP-seq Analyses of the Growth Inhibition Response Program of the Androgen Receptor
- (2009) Biaoyang Lin et al. PLoS One
- CCN3 – A key regulator of the hematopoietic compartment
- (2008) L. McCallum et al. BLOOD REVIEWS
- CCN3/Nephroblastoma Overexpressed Matricellular Protein Regulates Integrin Expression, Adhesion, and Dissemination in Melanoma
- (2008) V. Vallacchi et al. CANCER RESEARCH
- Activated Androgen Receptor Downregulates E-Cadherin Gene Expression and Promotes Tumor Metastasis
- (2008) Y.-N. Liu et al. MOLECULAR AND CELLULAR BIOLOGY
- Androgen receptor mediates the expression of UDP-glucuronosyltransferase 2 B15 and B17 genes
- (2008) Bo-Ying Bao et al. PROSTATE
- CCN3: Doctor Jekyll and Mister Hyde
- (2008) Bernard Perbal Journal of Cell Communication and Signaling
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started